Clinical trial
The Japan Working Group for the Assessment That the Pioglitazone Protects DM Patients Against Re-Infarction
NCT00212004 is registered in ClinicalTrials.gov with National Cerebral and Cardiovascular Center, Japan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Japan Working Group for the Assessment That the Pioglitazone Protects DM Patients Against Re-Infarction
- Lead sponsor
- National Cerebral and Cardiovascular Center, Japan
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- April 30, 2005
- Completion date
- April 30, 2018
- Enrollment
- 630 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.